Zealand Pharma

Danish biotech focused on peptide therapeutics. Petrelintide (amylin analog monotherapy, Phase 2, Roche partnership); dapiglutide; survodutide (Phase 3 dual GLP-1/glucagon partnered with Boehringer Ingelheim).